Home › Funds › Artia Global Partners LP › BLTE

Artia Global Partners LP position in BLTE

BELITE BIO INC · Health Care

Artia Global Partners LP reported holding 24,989 shares of BLTE (BELITE BIO INC) in its Q2 2026 13F filing — a position valued at US$3.8M, representing 0.71% of its reported portfolio and ranking #33 among its reported holdings. Artia Global Partners LP has disclosed BLTE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)24.99K sh
Reported value held$3.85M
Portfolio Weight0.71%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's BLTE position evolved

Artia Global Partners LP first disclosed a stake in BLTE in Q4 2025 at 17,989 shares (US$2.9M). The position peaked in Q1 2026 at 24,989 shares, worth US$4.0M. Across 3 filings, Artia Global Partners LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 24,989 shares valued at US$3.8M. Notable position changes include a 39% increase in Q1 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 17.99K $2.88M New
Q1 2026 24.99K $3.98M Add
Q2 2026 24.99K $3.85M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BLTE and 13F data

BLTE (BELITE BIO INC) is a Health Care company. 68 other funds we track also report a position in BLTE — the largest reported positions include Darwin Global Management, Ltd. (US$456.6M), Paradigm Biocapital Advisors LP (US$189.8M), RTW INVESTMENTS, LP (US$110.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BLTE

All BLTE fund holders →

FAQ

How long has Artia Global Partners LP held BLTE?

Artia Global Partners LP has disclosed BLTE holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Artia Global Partners LP's current position in BLTE?

As of Q2 2026, Artia Global Partners LP holds 24.99K shares of BLTE (BELITE BIO INC), valued at $3.85M, representing 0.71% of its reported portfolio and ranking #33.

Has Artia Global Partners LP been buying or selling BLTE?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in BLTE. The position peaked in Q1 2026 at 24.99K shares.

Which other funds hold BLTE?

Other major institutional holders of BLTE include Darwin Global Management, Ltd., Paradigm Biocapital Advisors LP, RTW INVESTMENTS, LP, among 68 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.